CareDx Transplant Managment, Inc. – Trademark Portfolio
Entity Type: 03
CareDx Transplant Managment, Inc. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 4 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 2 Nice Classification classes. Currently, 1 trademark is registered and 2 are pending. Notable registered marks include AIKIDNEY. The owner is based in Omaha, NE.
10202 F Street
Omaha, NE 68127
Showing of trademarks Trademarks
Trademark Classifications
CareDx Transplant Managment, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does CareDx Transplant Managment, Inc. have?
CareDx Transplant Managment, Inc. has 5 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 pending, 2 abandoned.
What trademark classes does CareDx Transplant Managment, Inc. file in?
CareDx Transplant Managment, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics). Class 42 covers scientific and technological services; industrial analysis and research services.
What are CareDx Transplant Managment, Inc.'s most well-known trademarks?
CareDx Transplant Managment, Inc.'s registered trademark portfolio includes well-known marks such as AIKIDNEY. These are among 1 currently registered trademark in the portfolio.
What is CareDx Transplant Managment, Inc.'s trademark registration success rate?
CareDx Transplant Managment, Inc. has a 33% trademark registration rate, with 1 out of 3 resolved applications resulting in successful registration. Currently, 2 applications are pending review.